New Delhi [India], April 30 (ANI): The Ministry of External Affairs (MEA) on Thursday said that India has provided 2.8 million hydroxychloroquine (HCQ) tablets, an anti-malarial drug, deemed useful in dealing with COVID-19, and 1.9 million paracetamol tablets as part of its assistance to oth
Ahmedabad (Gujarat) [India], April 24 (ANI): The Chairman of Indian Drug Manufacturers' Association, Gujarat chapter has asserted that there is no shortage of Hydroxychloroquine in India and the country's current production of HCQ is 35 to 40 crore tablets a month.
Basel [Switzerland], April 22 (ANI): Swiss multinational pharmaceutical company Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a phase three clinical trial with about 440 patients to evaluate the use of hydroxychloroquine for the treatment of
New Delhi [India] April 21 (ANI/NewsVoir): Morepen Laboratories Ltd is all set to be a frontrunner in India's fight against novel coronavirus disease, known as COVID-19.
New Delhi [India], April 18 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said it is conducting "observational study" on hydroxychloroquine (HCQ).
New Delhi [India], April 16 (ANI): A total of 55 countries have been approved to get Hydroxychloroquine (HCQ) drug out of which 21 countries will get it on a commercial basis and others on a grant, that is in very small quantities, informed sources told ANI on Thursday.
New Delhi [India], April 12 (ANI): The Central government on Sunday approved the release of Hydroxychloroquine (HCQ) for 13 countries after keeping the buffer stock.
New Delhi [India], April 12 (ANI): AIIMS Director Dr Randeep Guleria on Sunday warned the general public against the use of hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, without proper approval from doctors, stating that it can be harmful leading
New Delhi [India], April 11 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said that hydroxychloroquine or HCQ should be used as prophylaxis to prevent the coronavirus and not as a treatment for COVID-19.
Islamabad [Pakistan], April 11 (ANI): Pakistan has re-imposed the ban on export of all anti malaria drugs including hydroxychloroquine or HCQ, touted as a potential treatment for the coronavirus, four days after it lifted the hold on them.
Ahmedabad (Gujarat) [India], April 11 (ANI): With the surge in demand for hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, the pharmaceutical industry has produced 20 crore HCQ tablets this month, said Pankaj Patel, CEO of Zydus Cadila in Ahmedabad, on
Male [Maldives], April 11 (ANI): Foreign Minister of Maldives, Abdulla Shahid, on Friday (local time) thanked India for approving his country's request for hydroxychloroquine (HCQ), an anti-malarial drug, deemed useful in dealing with COVID-19.